Vulnerable Populations

FDA Approves Moderna’s mNEXSPIKE for Seniors and High-Risk Adults as CDC Drops Recommendations for Healthy Children and Pregnant Women

Moderna plans to roll out the shot ahead of the 2025–26 respiratory season